ELR CXC chemokine expression in benign and malignant colorectal conditions-7

< 0.05, ** < 0.001, = 30 (CRA), 48 (CRC) and 16 (CRLM), respectively. Fold increase above 1 indicates CXCR2 overexpression in CRA, CRC and CRLM tissues related to unaffected neighbor tissues, respectively.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-6

Ues of CRA, (B) very weak immunostaining in CRA specimens, (C) weak insular epithelial signals in tumor neighbor tissues of CRC, (D) intense basal and apical epithelial signals and interspersed rare mesenchymal signals in CRC tissues, (E) no substantial reactivity in corresponding neighbour tissues of CRLM and (F) intensive staining signals in epithelial and mesenchymal cells within tumor areas of CRLM specimens (original magnification 200 and 400 fold, respectively).<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-10

0.05, ** < 0.001, = 16 and 14, respectively. Fold increase above 1 indicates chemokine overexpression in affected tissues related to unaffected neighbor tissues, respectively.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-1

< 0.05, ** < 0.001, = 23 and 25, respectively. Fold increase above 1 indicates chemokine overexpression in CRC tissues related to unaffected neighbor tissues, respectively. Note the different scale for CXCL1, CXCL5 and CXCL6 expression.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-0

< 0.05, ** < 0.001, = 30 and 48, respectively. Fold increase above 1 indicates chemokine overexpression in CRA and CRC tissues related to unaffected neighbor tissues, respectively.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-3

per mg total protein in CRA and CRC tissues and unaffected neighbor tissues, respectively. The data are expressed as mean +/- standard error of the mean (SEM), * < 0.05, ** < 0.001, = 30 and 48, respectively. Note the different scale for CXCL1, CXCL5 and CXCL6 expression.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-8

< 0.05, ** < 0.001, = 30 and 48, respectively. Fold increase above 1 indicates chemokine overexpression in CRA and CRC tissues related to unaffected neighbor tissues, respectively.<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p

ELR CXC chemokine expression in benign and malignant colorectal conditions-5

Sues of CRA, (B) weak to medium staining intensities in apical epithelial cells within CRA specimens, (C) weak insular signals in apical epithelial cells and goblet cells within tumor neighbor tissues of CRC, (D) intense ubiquitous epithelial signals and insular mesenchymal signals in CRC tissues, (E) medium staining intensities of fine granular texture in hepatocytes and (F) intense cytoplasmic signals in ubiquitous distribution in CRLM (original magnification 200 and 400 fold, respectively).<p><b>Copyright information:</b></p><p>Taken from "ELR+ CXC chemokine expression in benign and malignant colorectal conditions"</p><p>http://www.biomedcentral.com/1471-2407/8/178</p><p>BMC Cancer 2008;8():178-178.</p><p>Published online 25 Jun 2008</p><p>PMCID:PMC2459188.</p><p></p